M. Carroll

发表

Time between Collection and Storage Significantly Influences Bacterial Sequence Composition in Sputum Samples from Cystic Fibrosis Respiratory Infections

L. Hoffman, J. Parkhill, A. Walker, 2014, Journal of Clinical Microbiology.

Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma

P. Howarth, G. Rogers, C. Grainge, 2014, PloS one.

Is there a case for n-3 fatty acid supplementation in cystic fibrosis?

P. Calder, S. Wootton, A. Cawood, 2005, Current opinion in clinical nutrition and metabolic care.

Primary ciliary dyskinesia: the patients grow up

C. Kuehni, M. Carroll, M. Goutaki, 2016, European Respiratory Journal.

Pulmonary radioaerosol mucociliary clearance in primary ciliary dyskinesia

J. Fleming, Michael J. Bennett, J. Conway, 2014, European Respiratory Journal.

Primary ciliary dyskinesia and cystic fibrosis: different diseases require different treatment.

M. Carroll, J. Lucas, 2014, Chest.

Complexity, Temporal Stability, and Clinical Correlates of Airway Bacterial Community Composition in Primary Ciliary Dyskinesia

K. Lock, G. Rogers, K. Bruce, 2013, Journal of Clinical Microbiology.

Application of an Asthma Screening Questionnaire in Children with Sickle Cell Disease.

Deborah L. Brown, M. Carroll, S. Hashmi, 2015, Pediatric allergy, immunology, and pulmonology.

Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset

L. Hoffman, J. Schwarze, G. Rogers, 2011, Expert review of molecular diagnostics.

Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis.

Z. Saynor, J. Shute, G. Connett, 2018, Journal of applied physiology.

A monocyte function test (complement receptor enhancement) to assess the extent of bronchial carcinoma.

A. Kay, M. Hodson, M. Carroll, 1987, Thorax.

A monocytefunction test(complement receptor enhancement) toassesstheextent ofbronchial carcinoma

A. Kay, M. Hodson, M. Carroll, 1987 .

Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects.

P. Howarth, R. Djukanović, S. Montefort, 1992, The European respiratory journal.

Analysis of the Bacterial Communities Present in Lungs of Patients with Cystic Fibrosis from American and British Centers

M. Wolfgang, S. Donaldson, R. Boucher, 2010, Journal of Clinical Microbiology.

Modelling the bacterial communities associated with cystic fibrosis lung infections

A. Lilley, K. Bruce, M. Carroll, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Respiratory microbiota: addressing clinical questions, informing clinical practice

D. Shaw, G. Rogers, R. Marsh, 2014, Thorax.

Leukocyte activation in allergen-induced late-phase asthmatic reactions.

S. Durham, A. Kay, M. Carroll, 1984, The New England journal of medicine.

COMPLEMENT RECEPTOR ENHANCEMENT AS EVIDENCE OF NEUTROPHIL ACTIVATION AFTER EXERCISE-INDUCED ASTHMA

A. Kay, T. Lee, M. Carroll, 1983, The Lancet.

Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways.

P. Howarth, S. Holgate, A. Frew, 1996, The Journal of allergy and clinical immunology.

Safety aspects of local endobronchial allergen challenge in asthmatic patients.

P. Howarth, N. Krug, S. Holgate, 1996, American journal of respiratory and critical care medicine.

Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation.

P. Howarth, S. Holgate, S. Montefort, 1996, American journal of respiratory and critical care medicine.

The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.

P. Marsh, G. Rogers, K. Bruce, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

L. Hoffman, Louic Vermeer, G. Rogers, 2012, Thorax.

Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics.

P. Howarth, S. Holgate, D. Davies, 1995, International archives of allergy and immunology.

Endobronchial allergen challenge.

N. Krug, A. Frew, M. Carroll, 1998, The European respiratory journal. Supplement.

Mucosal inflammation and asthma.

P. Howarth, R. Djukanović, S. Holgate, 1994, American journal of respiratory and critical care medicine.

Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release.

P. Howarth, S. Holgate, D. Davies, 1996, American journal of respiratory and critical care medicine.

Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways.

S. Holgate, D. Davies, J. Schröder, 1996, Journal of immunology.

Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways.

P. Howarth, S. Holgate, S. Montefort, 1994, The Journal of clinical investigation.

Early changes in T lymphocytes recovered by bronchoalveolar lavage after local allergen challenge of asthmatic airways.

P. Howarth, S. Holgate, M. Carroll, 1992, The American review of respiratory disease.

Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment.

S. Holgate, J. Shute, L. Teran, 1999, Cytokine.

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

A. Kay, H. Richerson, M. Carroll, 1987, The Journal of allergy and clinical immunology.

Cellular changes 24 hours after endobronchial allergen challenge in asthma.

S. Holgate, A. Frew, L. Teran, 1995, International archives of allergy and immunology.

The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN

M. Armengot, H. Omran, P. Yiallouros, 2022, ERJ Open Research.

Multiple breath washout in bronchiectasis clinical trials: is it feasible?

D. Cosgrove, J. Bradley, M. Tunney, 2020, ERJ Open Research.

Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.

I. Bradbury, D. Cosgrove, J. Bradley, 2018, Respiratory medicine.

The impact of plasma 25-hydroxyvitamin D on pulmonary function and exercise physiology in cystic fibrosis: a multicentre retrospective study.

Z. Saynor, G. Connett, M. Carroll, 2021, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Airway effects of local challenge with hypertonic saline in exercise-induced asthma.

P. Howarth, S. Holgate, S. Montefort, 1994, American journal of respiratory and critical care medicine.

Enhancement of leukocyte cytotoxicity after exercise-induced asthma.

S. Durham, A. Kay, M. Carroll, 1986, The American review of respiratory disease.

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

A. Mcguire, M. Clarke, J. Bradley, 2019, Trials.

Respiratory muscle function in patients with asbestos-related pleural disease.

J. Moxham, R. Rudd, M. Green, 1994, Respiratory medicine.

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis

S. Rice, S. Kjelleberg, S. Clarke, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction.

S. Durham, A. Kay, M. Carroll, 1985, The Journal of allergy and clinical immunology.

BronchUK: protocol for an observational cohort study and biobank in bronchiectasis

A. Mcguire, D. Denning, J. Bradley, 2021, ERJ Open Research.

Sniff esophageal and nasopharyngeal pressures and maximal relaxation rates in patients with respiratory dysfunction.

J. Moxham, M. Elliott, M. Green, 1991, The American review of respiratory disease.

Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing

A. Tuck, M. Carroll, D. Serisier, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Nasal intermittent positive pressure ventilation in acute exacerbations of chronic obstructive pulmonary disease--a preliminary study.

J. Conway, R. Hitchcock, M. Carroll, 1993, Respiratory medicine.

Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum

S. Young, J. Shute, M. Carroll, 2009, Respiratory research.

Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.

M. Carroll, D. Serisier, Graeme R. Jones, 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.

James R. Smith, J. Shute, M. Carroll, 2007, American journal of physiology. Lung cellular and molecular physiology.

Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics.

S. Holgate, S. Holgate, L. Teran, 1995, American journal of respiratory cell and molecular biology.

285 Bronchial mucosal intercellular adhesion molecule-1 [ICAM-1] and endothelial leukocyte adhesion molecule-1 [ELAM-1] expression in normals and asthmatics

P. Howarth, S. Holgate, S. Montefort, 1991 .

Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer.

A. Kay, M. Hodson, K. Lukacs, 1983, Clinical and experimental immunology.

ENHANCED NEUTROPHIL AND MONOCYTE CYTO-TOXICITY AFTER EXERCISE INDUCED ASTHMA

S. Durham, A. Kay, M. Carroll, 1985 .

Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling

G. Rogers, P. Hockey, K. Bruce, 2004, Journal of Clinical Microbiology.

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

G. Rogers, C. J. van der Gast, G. Connett, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing

A. Tuck, M. Carroll, D. Serisier, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses✩

L. Hoffman, J. Parkhill, A. Walker, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity

A. Walker, G. Rogers, K. Bruce, 2010, Expert review of molecular diagnostics.

Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches

G. Rogers, A. Tuck, G. Connett, 2009, BMC pulmonary medicine.

Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis

Z. Saynor, M. Lindley, M. Gruet, 2020, Redox biology.

PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia

B. Dimitrov, C. Kuehni, C. Hogg, 2016, European Respiratory Journal.

Topological data analysis reveals genotype–phenotype relationships in primary ciliary dyskinesia

G. Carlsson, J. Brandsma, N. S. Thomas, 2021, European Respiratory Journal.

M. Carroll, D. Serisier, 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Comparing the microbiota of the cystic fibrosis lung and human gut

D. Fine, A. Walker, G. Rogers, 2010, Gut microbes.

Studying bacterial infections through culture-independent approaches.

G. Rogers, K. Bruce, M. Carroll, 2009, Journal of medical microbiology.

Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

G. Rogers, K. Bruce, M. Carroll, 2012, British journal of pharmacology.

Lung function and microbiota diversity in cystic fibrosis

L. Hoffman, J. Parkhill, C. Teneback, 2020, Microbiome.

Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities

J. Parkhill, A. Walker, P. Scott, 2010, The ISME Journal.

Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy.

J. Conway, James R. Smith, T. Nevell, 2008, Journal of pharmaceutical sciences.

Fixed drug eruption: Aztreonam and ceftazidime cross-reactivity in cystic fibrosis, a case report

M. Carroll, P. Friedmann, C. Pickard, 2010 .

A quality-of-life measure for adults with primary ciliary dyskinesia: QOL–PCD

A. Quittner, M. Knowles, M. Leigh, 2015, European Respiratory Journal.

Reducing bias in bacterial community analysis of lower respiratory infections

L. Hoffman, Anna E. Oliver, G. Rogers, 2012, The ISME Journal.

Interpreting infective microbiota: the importance of an ecological perspective.

L. Hoffman, G. Rogers, K. Bruce, 2013, Trends in microbiology.

Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.

K. Bruce, M. Carroll, M. Payne, 2009, Diagnostic microbiology and infectious disease.

Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.

G. Rogers, K. Bruce, M. Carroll, 2008, Diagnostic microbiology and infectious disease.

Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

G. Rogers, G. Connett, P. Hockey, 2006, Journal of Clinical Microbiology.

Use of 16 S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis †

G. Rogers, G. Connett, P. Hockey, 2006 .

Bacterial activity in cystic fibrosis lung infections

G. Rogers, P. Hockey, K. Bruce, 2005, Respiratory research.

Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention

J. Parkhill, A. Walker, Anna E. Oliver, 2015, The ISME Journal.

Cystic Fibrosis Respiratory Infections Composition in Sputum Samples from Significantly Influences Bacterial Time between Collection and Storage

L. Hoffman, J. Parkhill, A. Walker, 2014 .

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

J. Wedzicha, E. Paul, S. Keilty, 1993, The Lancet.

Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life.

A. Simonds, M. Elliott, M. Elliott, 1992, Thorax.

CARDIOPULMONARY EXERCISE TESTING WITH SUPRAMAXIMAL VERIFICATION PRODUCES A SAFE AND VALID ASSESSMENT OF V̇O2max IN PEOPLE WITH CYSTIC FIBROSIS.

Z. Saynor, J. Shute, G. Connett, 2018, Journal of applied physiology.

A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation

Louic Vermeer, G. Rogers, D. Rivett, 2013, Metabolomics.

Whole genome sequencing in the diagnosis of primary ciliary dyskinesia

N. S. Thomas, D. Hunt, V. Mennella, 2021, BMC Medical Genomics.

Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis.

N. Woodford, J. Turton, T. Winstanley, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis

S. Rice, S. Kjelleberg, S. Clarke, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register

J. Nightingale, Z. Hoo, D. Hind, 2021, Health science reports.

Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.

L. Hoffman, G. Rogers, M. Whiteley, 2010, Trends in microbiology.

Inhaled heparin in cystic fibrosis

J. Conway, J. Shute, P. Hockey, 2006, European Respiratory Journal.

Title : Low dose nitric oxide as targeted anti-biofilm adjunctive therapy to 1 treat chronic Pseudomonas aeruginosa infection in cystic fibrosis 2 3

S. Rice, S. Kjelleberg, S. Clarke, 2017 .

Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?

L. Hoffman, G. Rogers, A. Lilley, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Receptor associated defects of cultured monocytes in bronchial carcinoma.

A. Kay, M. Hodson, K. Lukacs, 1984, Clinical and experimental immunology.